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Summary
Malformations are common causes of pediatric morbid-
ity and mortality, and genetic factors are a significant
component of their etiology. Autosomal deletions, in al-
most all cases, cause a nonspecific embryopathy that
presents after birth as growth failure,mental retardation,
and multiple malformations. We have constructed a
chromosome map of autosomal deletions associated
with 47 different congenital malformations, using de-
tailed clinical and cytogenetic information on 1,753 pa-
tients with nonmosaic single contiguous autosomal de-
letions. The 1,753 deletions involved 258 (89%) of 289
possible autosomal bands (by the use of ISCN 400-band
nomenclature), giving a total of 4,190 deleted autosomal
bands for analysis. We compared the band distributions
of deletions associated with common major malforma-
tions with the distribution of all 1,753 deletions. We
noted 283 positive associations between deleted bands
and specific malformations, of which 199 were signifi-
cant ( ) and 84 were highly significantP ! .05, P 1 .001
( ). These “malformation-associated bands”P ! .001
(MABs) were distributed among 137 malformation-as-
sociated chromosome regions (MACRs). An average of
6 MABs in 2.9 MACRs were detected per malformation
studied; 18 (6%) of 283 MABs contain a locus known
to be associated with the particular malformation. A
further 18 (6%) of 283 are in seven recognized specific
malformation-associated aneuploid regions. Therefore,
36 (26%) of 137 of the MACRs contain an MAB co-
inciding with a previously recognized locus or malfor-
mation-associated aneuploid region. This map should
facilitate identification of genes important in human
development.
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Introduction
In developed countries, malformations account for 21%
of pediatric hospital admissions (Hall et al. 1978), 39%
of pediatric intensive care–unit admissions (FitzPatrick
et al. 1991), and 48% of deaths in full-term neonates
(Hogue et al. 1989). Kalter and Warkany (1983) esti-
mated that 6% of all congenital malformations are due
to visible cytogenetic abnormalities. Several areas of in-
vestigation (twin studies [Hrubel and Robinette 1984],
familial aggregation [Khoury et al. 1988], analysis of
interracial crossing [Chung and Myrianthopoulos
1968], and rare Mendelian traits [Wilkie 1994]) provide
evidence that genetic factors play a significant causative
role in birth defects. Very few of these genes have, as
yet, been characterized.
In humans, cytogenetically visible autosomal deletions
have a live birth incidence of ∼1 in 7,000 (Jacobs et al.
1992). Over the last 25 years, autosomal deletions have
been used extensively in human gene mapping to order
genes in contiguous gene defects (Ballabio 1991) and
have provided the first clues to the map location of many
genetic loci (Ferguson-Smith and Aitken 1982). As yet,
no systematic approach to mapping the phenotypic as-
sociations of segmental hypoploidy has been undertaken
in humans, although this approach has been suggested
elsewhere (Lewandowski et al. 1977). Such an analysis
may facilitate the identification of genes involved in hu-
man site-specific malformations. We present herein a
first-generation chromosome-deletion map.
Material and Methods
Case Ascertainment and Deletion Definition
The Human Cytogenetics Database (HCDB) is a com-
mercially available computerized catalog of postnatally
ascertained, cytologically detectable human chromoso-
mal aberrations (Schinzel 1994). We extracted cytoge-
netic and clinical data on individuals with nonmosaic
uncomplicated deletions (those involving a single con-
tiguous region of autosomal DNA). In view of the mod-
ifying influence of segmental trisomies on deletions (Lu-
rie 1993), the presence of any other aneuploid region
excluded individuals from further analysis. International
System for Human Cytogenetic Nomenclature (ISCN)
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400-band nomenclature (Mittelman 1995) was used to
describe the deletions, and breakpoint bands were scored
as deleted. Deletions involving subbands were scored as
including the whole band. This gave a total of 289 whole
autosomal bands. To assess how accurately the distri-
bution of HCDB deletions represents that in the overall
population, we compared it with cases of uncomplicated
autosomal deletions presented in the Constitutional
Chromosome Abnormality Database (CCAD). This
database is funded by theOxford and East AngliaHealth
Authority, and it catalogs all abnormal cytogenetic re-
ports from ∼70% of UK cytogenetic laboratories. The
CCAD individuals had received diagnoses in postnatal
life by analysis of metaphase chromosomes obtained
from peripheral blood lymphocyte culture.
Statistical Analysis
The distribution of deleted bands in patients with 47
different congenital malformations was then determined.
These specific malformations were chosen as common,
major malformations that cover a wide spectrum of de-
velopmental processes. For some malformations—for
example, gastroschisis, esophageal atresia, and radial ray
defects—the numbers associated with simple deletions
were too small to allow valid analysis. For each mal-
formation studied, the observed number of deletions of
a particular band was compared with the expected num-
ber calculated from the band distribution of all 4,190
band deletions. Confidence limits for the observed num-
ber of deletions and the significance of any deviation
from expected were calculated as described by Vasar-
helyi and Friedman (1989). The number of deletions in
any band was taken to follow a Poisson distribution,
since total deletions and the number of deletions in any
band were usually small. Chromosome bands found to
be significantly ( ) and highly signifi-P ! .05, P 1 .001
cantly ( ) associated with a given malformationP ! .001
were termed “malformation-associated bands” (MABs).
The analyses of sex ratios and the comparison of dis-
tribution of cases between HCDB and CCAD were sim-
plified by grouping the deletions by the chromosome arm
containing the deleted region (unless the number of de-
letions on that arm was !10, in which case they were
grouped by whole chromosome). Chromosome 19 was
excluded from analysis because of the very small number
of reported deletions involving this chromosome (1/
1,753), leaving a total of 33 chromosomal categories
(deletion groups). The Spearman rank correlation co-
efficient was calculated between the number of deletions
in each deletion group in the two databases. Compari-
sons were also made, between the two groups, of the
proportions of all deletions in each of the 33 deletion
groups, with correction for the number of tests carried
out. We compared the sex ratios of individuals in the
33 deletion groups by comparing the proportion of
males in each group with that in the rest of the groups
combined and by correcting for the number of tests
made.
The Wilcoxon rank sum test was used to compare the
band size distribution in each malformation group with
that for all other deletions considered together. In this
analysis, the number of bands involved in each deletion
was used as an estimate of deletion size. We also esti-
mated deletion size by measuring the length of each de-
letion on the ISCN karyotype and expressing this as a
percentage of the autosomal haploid genome. There was
a highly significant correlation between these two values
(correlation coefficient 0.69, ).P ! .001
Results
General Information
A total of 1,753 individuals with uncomplicated au-
tosomal deletions were identified, representing approx-
imately one-third of all cases in HCDB; 258 (89%) of
the 289 possible autosomal bands were involved in one
or more deletions. This gave a total of 4,190 band de-
letions that were used for analysis. No deletions were
recorded in 31 (11%) of 289 autosomal bands.
MABs
In the 47 malformations chosen for study, 283 MABs
were identified (199 in which , 84 inP ! .05, P 1 .001
which ) and 138 different bands were involvedP ! .001
(fig. 1, table 1). The average number of associated bands
detected per malformation was 6 (range 0–13), of which
4.3 were significant ( ) and 1.8 wereP ! .05, P 1 .001
highly significant ( ). The chromosome regionsP ! .001
containing no significant loci were 5p, 8q, 12p, 16p, 19,
and 20q.
Deletion Size
Seven of the malformations (anal atresia, cleft lip, cleft
palate, micrognathia, hydrocephalus, microphthalmia,
and talipes) were associated with deletion sizes signifi-
cantly larger than the rest of the group and two (aniridia
and cataract) with deletions involving significantly fewer
bands ( ).P ! .01
Distribution of Deletions in HCDB
The deletion group distribution of HCDB individuals
was compared with 937 individuals with uncomplicated
autosomal deletions extracted from CCAD. The distri-
bution of deleted chromosomal material across the ge-
nome was nonrandom in both HCDB and CCAD, and
there was a highly significant correlation between the
distributions in these two groups ( ).r  0.665, P ! .001
Figure 1 Diagrammatic representation of G-banded autosomal karyotype indicating locations of MABs
Table 1
Regions of Autosomal Hypoploidy Significantly Associated with Specific Malformations
Malformation
No. of
Cases
All Significantly Associated Bands
( )P ! .05, P ! .01, P ! .001
Highly Significantly
Associated Bands
( )P ! .001
Craniofacial:
Cleft palate 269 2q32, 4p16-13, 4q31-35 4p16-14, 4q31-35
Cleft lip 95 1q21-25, 4p16-15, 4q31-35, 7q34-35 1q25,4q31-35
Micrognathia 653 4p16-14, 4q31-35, 6q25-27, 11q23 4p16-15
Choanal atresia 11 7q11-21, 10p11
Cardiac:
Patent ductus arteriosus 94 4q32, 6p25-23, 9q31
Atrial septal defect 97 4p13, 4p16, 10p12-11, 12q15
Ventricular septal defect 166 1q42-44, 3q24-25, 4q31-34, 11q23-25, 22q11 4q31, 22q11
Atrioventricular septal defect 16 6q15-21, 6q23, 8p23, 16q13-22
Pulmonary stenosis 71 7q31, 8p23, 17p13, 20p13-11 20p13-11, 22q11
Hypoplastic left heart 14 11q23-25 11q23-25
Aortic stenosis 23 3p14-11, 11q23-24 11q23-24
Truncus arteriosus 15 2q22-23, 11q23, 22q11 2q22,22q11
Tetralogy of fallot 37 8p22-21, 22q11
Coarctation 23 4q31-32, 5q23-31
Skeletal and limb:
Scoliosis 114 2p15-13, 6q13, 15q12
Pectus excavatum 60 6p23, 18p11
Talipes equina varus 176 2q31-33, 3q23-24, 4p16-14, 7p22, 13q33-34,
18q22-23
Syndactyly of fingers 38 7p21, 7q33 7p21, 7q33
Postaxial polydactyly 27 3p26-25 3p25
Split hand 7 7q11-22 7q21-22
Absent sacrum 9 7q32-36 7q36
Gastrointestinal:
Small bowel atresia 14 13q33-34
Anal atresia 36 13q22-34 13q22-34
Hirschprung’s syndrome 11 13q22-32, 17q21
Intestinal malrotation 29 1p21-13, 1q41, 3p14-13, 13q22-34
Umbilical hernia 112 6q12-15, 9p22, 9q32-34
Genitourinary:
Renal agenesis 19 1q21-32, 5q32-35, 16q22 1q31
Multiple renal cysts 18 5q32-35, 15q24, 17p13
Hydronephrosis 40 7q36
Hypospadias 152 1q42-44, 4p16-13, 7q34, 11p13
Cryptorchidism 267 10p15-13, 10q26, 11p13, 15q11, 15q13 10p15-14, 11p13
Inguinal hernia 115 7q11-21, 9p24-22 7q11-12
Ambiguous genitalia 23 11p13,13q22-34 11p13, 13q31-34
Ocular:
Microphthalmia 86 1p32-31, 1q41, 13q21-34, 15q23 13q22-34
Coloboma 81 2p22-21, 4p16-13, 4q25-27, 11q23-25, 13q31-34 4p16-14
Cataract 61 2q23, 4p14, 11p13, 18q11-12 11p13
Aniridia 54 11p13 11p13
Anophthalmia 3 14q22-23 14q22-23
Glaucoma 25 7q31, 11p13, 14q13-22 11p13, 14q13-21
CNS:
Microcephaly (prenatal) 261 1q21-25, 1q32, 1q42-44, 2p21, 4p16-15, 7q33-
36, 13q31-34, 21q22
4p16-15
Hydrocephalus 139 1q42-43, 2q31, 6q16, 15q14
Holoprosencephaly 55 2p22-21, 7q32-36, 13q22-34, 18p11 2p21, 7q32-34, 7q36,
13q33-34, 18p11
Agenesis corpus callosum 64 1q42-43, 4q22 1q42-43
Lissencephaly 12 17p13, 22q13 17p13
Craniosynostosis 30 2q13-14, 6q22-23, 7p22-15 7p21-15
Trigonocephaly 103 7p22-21, 9p24-13, 11q22-25, 13q32-34 9p24-21, 11q23-25
Scalp defects 10 4p16-15, 18q12
NOTE.—All bands for which are included in the 3d column; of these, the highly significant associations, for which , areP ! .05 P ! .001
indicated in the 4th column.
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Table 2
MABs Containing Loci Identified by Linkage or Mutation Analysis
Malformation MAB
Known Locus
(MIM Number)
Holoprosencephaly 2p23-22 HPE type 2 (157170)
Atrial septal defect 4p13 Ellis–van Creveld (225500)
Craniosynostosis 7p21-15 Saethre Chotzen (101400)
Trigonocephaly 7p22-21 Saethre Chotzen (101400)
Split hand 7q11-22 EEC-1 syndrome (129900)
Choanal atresia 7q11-21 EEC-1 syndrome (129900)
Absent sacrum 7q32-36 Sacral agenesis (176450)
Holoprosencephaly 7q32-36 HPE type 3 (142945)
Cryptorchidism 11p13 WT-1 (137357)
Ambiguous genitalia 11p13 WT-1 (137357)
Cataract 11p13 AN-1 (106210)
Glaucoma 11p13 AN-1 (106210)
Aniridia 11p13 AN-1 (106210)
Hirschprung’s
syndrome
13q22-32 HSCR-2 (600155)
Renal cysts 15q24 Bardet-Biedl (209901)
Lissencephaly 17p13 LIS-1 (601545)
Holoprosencephaly 18p11 HPE type 4 (142946)
Pulmonary stenosis 20p13-11 JAG1 (601920)
It was noted that deletions involving 1q, 4p, 13, and
18p were significantly overrepresented in HCDB but de-
letions involving 5p and 15 were significantly under-
represented.
Sex Ratios
The male:female ratio was 0.85 (794:935), with 24
cases (1.37%) in which the phenotypic sex was ambig-
uous or not recorded. There were no significant differ-
ences in the male:female ratios in the deletion groups.
Known Malformation-Associated Loci
A search of the Online Mendelian Inheritance in Man
database was then performed to look for known Men-
delian loci associated with each malformation. Eighteen
(6%) of 283 MABs contain a locus, identified by linkage
or mutation analysis, associated with the particular mal-
formation (table 2). Therefore, 18 (13%) of 137MACRs
contain a known corresponding locus. A further 18 (6%)
of 283 are in regions of recognized aneuploid syndromes.
Discussion
Remarkable similarities have been noted in the effects
of segmental aneuploidy in species as diverse as humans
and Drosophila melanogaster (Lindsley et al. 1972). A
generally applicable rule is that phenotypes associated
with deletions are more severe than those associatedwith
duplications, with a maximum tolerance in viable or-
ganisms of 3% and 10% of the genome, respectively
(Hecht and Hecht 1987). It is also generally accepted
that human autosomal deletions produce certain non-
specific phenotypic effects, such as intrauterine growth
retardation and mental handicap. However, the clinical
recognition of deletion-specific syndromes (e.g., 4p
[Wolf-Hirschhorn], 5p [cri du chat], and 11q [Jacobson])
supports the assumption that haploinsufficiency for at
least some of the genes in the deleted region has a direct
effect on specific developmental processes. If this as-
sumption is correct, then the recognition of significant
associations between a particular malformation and
haploinsufficiency at a cytogenetic locus may facilitate
the identification of causative mutations in cytogeneti-
cally normal individuals with that malformation. This
approach is supported by several notable successes in
the use of human constitutional autosomal deletions to
localize or clone specific malformation-causing genes
(Tommerup et al. 1992; Muenke et al. 1994; Lynch et
al. 1995; Roessler et al. 1996).
Given this evidence, it is perhaps surprising that a
systematic chromosomal deletion map in humans has
not been attempted before. One reason for this may be
the complex nature of many human aneuploidies with
both trisomic and monosomic regions present in the
same individual. We have chosen to discount such cases
and limit our analysis to individuals with nonmosaic
deletions of a single contiguous region of autosomal
DNA. This was done to exclude the modifying action
of trisomic regions on deletions (Epstein 1993) but, ob-
viously, it cannot eliminate other genetic background
effects that exist in such a complex genome. It should
also be noted that we did not attempt to analyze parent-
of-origin effects, since this information was not available
for the majority of cases.
Several recent advances in human and other mam-
malian genomics have prompted this study. First, a gene
map of the human genome has been constructed by re-
gionally mapping ∼20% of all human transcripts in the
form of expressed sequence (ES) tags (Shuler et al. 1996).
This resource enables investigators to identify candidate
genes in any cytogenetic region of interest. Second, the
recognition of regions of human-mouse synteny
throughout the genome will allow the integration of the
map locations of developmental mutations in both spe-
cies. The ongoing projects to create an atlas of gene
expression data in the mouse embryo (Ringwald et al.
1994) and targeted deletion mutants in mouse ES cells
(Yun et al. 1997) may also improve candidate gene se-
lection in humans. Third, the ability to use polymorphic
genetic markers in mapping non-Mendelian traits in-
volves powerful but expensive and time-consuming lab-
oratory and computational techniques (Risch and Mer-
ikangas 1996). The deletion map may be useful in
obviating the need for whole genome scans as a first
approach to the identification of disease genes.
Several factors mean that this map must be interpreted
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with care. First, the degree to which the ascertainment
of uncomplicated deletions in the database is complete
is unknown. Second, the deletions cataloged in HCDB
are not completely representative when compared with
deletions in CCAD. However, most of the underrepre-
sentation in HCDB can be accounted for by specific de-
letions involving the Prader-Willi/Angelman (15q) and
cri du chat (5p) loci. The reason that deletions involving
1q, 4p, 13, and 18p are apparently overrepresented is
not clear. It is also interesting that seven malformations
were associated with significantly larger deletions, and
this may simply reflect a nonspecific embryopathy. An-
iridia and cataract were associated with significantly
smaller deletions on 11p, and this may reflect a high
phenotypic penetrance of haploinsufficiency at this lo-
cus. Interestingly, PAX6, which maps to 11p13 and is
mutated in individuals with aniridia (Jordan et al. 1992),
shows exquisite developmental dosage dependence
(Schedl et al. 1996). Third, a potential bias in HCDB is
that a report of a particular malformation in a patient
with a deletion is likely to lead to that malformation
being specifically sought in future cases. This bias would
apply particularly to asymptomatic internal malforma-
tions that may be difficult to detect on routine clinical
examination (e.g., atrial septal defects). This may be a
particular problem where the numbers of individuals
with a specific malformation are small (e.g., choanal
atresia) (table 1). Fourth, the accuracy of breakpoints
recorded in HCDB is not known. Such inaccuracies
mean that the MAB results should be seen as clues to
particular chromosomal regions rather than specific sig-
nificant bands. Fifth, the statistical method of identifying
the MAB could be criticized when it is used with the
whole group, rather than the whole group without the
test cases, to define the “deletability” of each band. This
approach was necessary, since an independent measure
of deletability was not available. However, the approach
we have taken should bias against finding MABs, since
the individuals are being tested in part against them-
selves. This article should be seen as merely suggesting
those chromosome regions where the search for loci in-
volved in the etiology of the malformations is most likely
to be fruitful.
Finally, although the association of a specified mal-
formation with a particular chromosome deletion is ev-
idence that haploinsufficiency of a gene (or genes) in that
region is responsible, this method would not be expected
to reliably identify the locations of recessive genes and
would not identify disease genes acting via other mech-
anisms of genetic dominance (Wilkie 1994).
We plan to develop this map by searching the database
for combinations of malformations, to identify candi-
date deletion groups for syndromes that involve multiple
malformations. We are also in the process of developing
a similar map for autosomal duplications.
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